Reata Pharmaceuticals Inc (NASDAQ:RETA)
| 42.23 Delayed Data As of 3:59pm ET |  -1.20 / -2.76%Today’s Change | 18.47 Today|||52-Week Range 46.90 | +11.16% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Assets | Cash | 138.7M | 375.2M | 337.8M | 313.1M | |
| Short Term Investment Cash | 32.7M | 236.5M | -37.4M | -24.7M | ||
| Cash & Short Term Investments | 138.7M | 375.2M | 337.8M | 313.1M | ||
| Receivables | Receivables | 30.5M | 0.00 | 0.00 | 0.00 | |
| Inventories | Inventories | -- | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 3.3M | 4.6M | 4.5M | 4.4M | |
| Current Assets | 172.4M | 379.8M | 342.3M | 317.5M | ||
| Total Assets | Property, Plant and Equipment - Gross | -- | -- | 14.2M | -- | |
| Depreciation | -- | -- | -12.7M | -- | ||
| Other Assets | 1.5M | 1.5M | 1.5M | 1.5M | ||
| Total Assets | 174.7M | 382.1M | 345.2M | 331.3M | ||
| Liabilities | Accounts Payable | 2.1M | 5.0M | 4.5M | 3.5M | |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 2.1M | ||
| Accrued Expenses | 15.3M | 18.4M | 15.4M | 16.3M | ||
| Other Current Liabilities | 53.6M | 57.9M | 51.4M | 55.6M | ||
| Other Liabilities | 55.7M | 62.9M | 55.9M | 61.2M | ||
| Total Liabilities | Long Term Debt | 78.6M | 78.9M | 79.2M | 87.5M | |
| Other Liabilities | 1.0M | 531.0K | 524.0K | 500.0K | ||
| Total Liabilities | 342.6M | 344.6M | 330.0M | 335.9M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | -167.9M | 37.5M | 15.2M | -4.6M | ||
| Total Shareholder Equity | -167.9M | 37.5M | 15.2M | -4.6M | ||
| Share Information | Common Shares Outstanding | 26.2M | 29.7M | 29.7M | 30.0M | |
| Addtl. Info. | No data currently available for this section. | |||||
